University Hospital Tuebingen
Tübingen, Germany
NCT Number: NCT05037344
Internet-based psychotherapy for children and adolescents with obsessive-compulsive symptoms and an age of 6 to 18 years. Sessions are verified with teleconferencing with an psychotherapist, children and their parents. The psychotherapy is supported by an App and a wristband to obtain psychophysiological data. The investigators have already successfully performed a feasibility study.The goal of the current proposal is to develop an internet and smart phone delivered CBT (iCBT) for the treatment of pediatric OCD on the bases of the feasibility study. Internal testing on iCBT therapy package and developmental workchanges has been done. The investigators are now evaluating effectiveness in an RCT.
Looking for future studies?
Notify Me6 year–18 year
All sexes
Interventional
Not applicable
Tübingen, Germany
In this study the investigators test effectiveness of an internet-based therapy approach for children with obsessive-compulsive disorders in an RCT design with a waiting control group. The investigators are planninng the investigation of 20 patients in each group.Therapy is verified by experts via teleconferences and a therapy app. Outcomes for the treatment group are evaluated before randomization (baseline, t0), 16 weeks (end of treatment, t1), 32 weeks (follow-up 1, t2), and 48 weeks after randomization (follow-up 2, t3). For the waiting list-group, outcomes are measured before the first randomization (baseline), at 16 weeks (waiting list period), 32 weeks (end of treatment), 48 weeks after the first randomization (follow-up I) and 64 weeks after the first randomization (follow-up II).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The goal is to develop an internet and smart phone delivered CBT (iCBT) for the treatment of pediatric OCD on the bases of our feasibility study. This group will start directly with therapy of 16 weeks. The waiting group gets the same intervention after 16 weeks of waiting.
Time frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Clinical interview for psychiatric disorders for children and parents.
Time frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Interview/questionnaire for obsessive-compusive disorders.
Time frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
The CGAS is a measure of level of functioning in children and adolescents.
Time frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
A 113-item 3-point questionnaire for parents that assesses a wide range of child behavioral and emotional problems.
Time frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
A 24 item 5 point scale self-report questionnaire for children and parents to quality of life.
Time frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
A 33-item self-report questionnaire to the impact of OCD symptoms on the psychosocial functioning of the children.
Time frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
A 112 item 3-point scale completed by the children themselves and addresses a variety of behavioral and emotional problems.
Time frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
The questionnaire measures depressive symptoms in the children. It has 26 items and a 4 point scale.
Time frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
The questionnaire assesses temperament characteristics with 103/86 items and a 5-point scale.
Time frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
The SCARED assesses DSM-IV anxiety symptoms.
Time frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
A clinical 7-point rating scale of symptom severity.
Time frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
A clinical 7-point rating scale of symptom severity.
Time frame: Every day throughout the therapy process
Children and parents indicate impairment by OCD via app.
Time frame: Every day throughout the therapy process
Children and parents indicate extend of avoidance behavior via app.
Time frame: Every day throughout the therapy process
Children indicate their mood via app.
Time frame: Every day throughout the therapy process
Children indicate how good the day has been via app.
Time frame: Every day throughout the therapy process
Children and parants indicate how strong OCD is via app.
Time frame: weekly throughout the therapy process
Children and parants indicate how the week has been via app.
Time frame: Every exposure throughout the therapy process
Children indicate how high anxiety was during exposures via app.
Time frame: Every day throughout the therapy process
Heart rate variability as an indicator of stress levels is assessed with wristbands.
Time frame: Every day throughout the therapy process
Children and parants indicate how much time OCD takes via app.
Time frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
This questionnaire assesses the core personality traits of children.
Time frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Questionnaire for emotional, cognitive and behavioral engagement at school with 5 items each.
Time frame: every exposure
assessed by App
Time frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Questionnaire to life quality of parents related to the impairment through the illness of the child.
Time frame: baseline
This is a 5-point scale and 28 items that measures trauma experience such as sexual abuse or emotional neglect.
Time frame: baseline
This questionnaire measures posttraumatic symptoms.
Time frame: baseline
This is a 24-item measure to traumatic events.
University Hospital Tuebingen
Other
Internet-based Cognitive Behavioral Psychotherapy for Children and Adolescents With Obsessive-compulsive Disorder II
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06670729
Discomfort, Fear Anxiety
Baghdad, Iraq
View Trial DetailsNCT05552014
Anxiety Disorders, Mental Disorders
Hefei, Anhui, China
View Trial DetailsNCT04967560
Anxiety Disorders, Mental Disorders
Zhengzhou, Henan, China
View Trial DetailsNCT05503017
Anxiety Disorders, Generalized Anxiety Disorder
Tallahassee, Florida, United States
View Trial Details